newsfilter
← Latest News
PR Newswire·

VolitionRx Participates in Launch of DETECSEPS Program in France

VolitionRx Limited (NYSE AMERICAN: VNRX) (XASE: VNRX) (together with affiliates, "Volition"), a multi-national epigenetics company, today announces,...